HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 160 filers reported holding HERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.49 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,759 | -11.3% | 1,708 | 0.0% | 0.00% | – |
| Q2 2023 | $1,982 | -23.1% | 1,708 | 0.0% | 0.00% | – |
| Q1 2023 | $2,579 | -39.6% | 1,708 | 0.0% | 0.00% | – |
| Q4 2022 | $4,270 | -46.6% | 1,708 | -19.0% | 0.00% | – |
| Q3 2022 | $8,000 | +60.0% | 2,108 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -66.7% | 2,108 | -12.2% | 0.00% | – |
| Q1 2022 | $15,000 | -6.2% | 2,401 | +40.6% | 0.00% | – |
| Q4 2021 | $16,000 | -11.1% | 1,708 | 0.0% | 0.00% | – |
| Q3 2021 | $18,000 | -76.9% | 1,708 | -65.8% | 0.00% | – |
| Q2 2021 | $78,000 | +25.8% | 5,000 | +31.2% | 0.00% | – |
| Q1 2021 | $62,000 | -21.5% | 3,811 | +2.4% | 0.00% | – |
| Q4 2020 | $79,000 | +21.5% | 3,720 | -15.6% | 0.00% | – |
| Q3 2020 | $65,000 | +6.6% | 4,409 | +6.6% | 0.00% | – |
| Q2 2020 | $61,000 | +90.6% | 4,136 | +53.3% | 0.00% | – |
| Q1 2020 | $32,000 | +128.6% | 2,698 | +325.6% | 0.00% | – |
| Q4 2019 | $14,000 | -6.7% | 634 | -23.2% | 0.00% | – |
| Q3 2019 | $15,000 | +25.0% | 826 | +28.7% | 0.00% | – |
| Q2 2019 | $12,000 | -99.3% | 642 | -99.1% | 0.00% | -100.0% |
| Q1 2019 | $1,802,000 | +48.2% | 73,748 | +57.3% | 0.00% | +100.0% |
| Q4 2018 | $1,216,000 | -22.0% | 46,881 | -4.7% | 0.00% | 0.0% |
| Q3 2018 | $1,558,000 | -17.8% | 49,212 | +0.9% | 0.00% | -50.0% |
| Q2 2018 | $1,895,000 | +7795.8% | 48,793 | +3152.9% | 0.00% | – |
| Q3 2017 | $24,000 | +14.3% | 1,500 | 0.0% | 0.00% | – |
| Q2 2017 | $21,000 | -8.7% | 1,500 | 0.0% | 0.00% | – |
| Q1 2017 | $23,000 | +15.0% | 1,500 | 0.0% | 0.00% | – |
| Q4 2016 | $20,000 | +53.8% | 1,500 | +93.1% | 0.00% | – |
| Q3 2016 | $13,000 | -7.1% | 777 | 0.0% | 0.00% | – |
| Q2 2016 | $14,000 | -73.6% | 777 | -72.0% | 0.00% | – |
| Q1 2016 | $53,000 | -50.0% | 2,777 | -30.2% | 0.00% | – |
| Q4 2015 | $106,000 | +107.8% | 3,977 | +93.3% | 0.00% | – |
| Q3 2015 | $51,000 | -17.7% | 2,057 | +4.0% | 0.00% | – |
| Q2 2015 | $62,000 | – | 1,977 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |